Amalgamated Financial’s Covetrus, Inc. Common Stock CVET Stock Holding History

Amalgamated Financial’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$778K	Buy	+46,361	New	+$810K	0.01%	1301

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Amalgamated Financial's CVET Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Covetrus, Inc. Common Stock (CVET) in Q1 2022: 46,361 shares worth $778K. The stake represents 0.01% of the portfolio and ranks #1301 among its holdings.

257 funds tracked by Wall St. Rank hold CVET as of Q1 2022.

Amalgamated Financial held 46,361 shares of Covetrus, Inc. Common Stock worth $778K as of Q1 2022.
Covetrus, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
Covetrus, Inc. Common Stock made up 0.01% of Amalgamated Financial's portfolio in Q1 2022, its #1301 holding.
257 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.